2026
Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.
Shuo-Feng Li, Guan-Hua Yu, Shi Feng, Ming-Jian Piao, Zixiang Zhou, Cheng-Jie Li, Zi-Yu Xun, Bo-Yu Sun, Jiong-Yuan Li, Na Zhang, Yongliang Sun, Zhen-Yu Zhu, Hai-Tao Zhao
Chinese Medical Journal